An Antagonistic Axon-Dendrite Interplay Enables Efficient Neuronal Repair in the Adult Zebrafish Central Nervous System.
Animals
Axons
/ drug effects
Central Nervous System
/ physiology
Dendrites
/ drug effects
Matrix Metalloproteinase Inhibitors
/ pharmacology
Nerve Crush
Nerve Regeneration
/ drug effects
Optic Nerve Injuries
/ pathology
Retinal Ganglion Cells
/ drug effects
TOR Serine-Threonine Kinases
/ antagonists & inhibitors
Zebrafish
/ physiology
Axonal regeneration
Dendritic remodeling
Optic nerve crush
Retina
Zebrafish
mTOR and MMP inhibitor studies
Journal
Molecular neurobiology
ISSN: 1559-1182
Titre abrégé: Mol Neurobiol
Pays: United States
ID NLM: 8900963
Informations de publication
Date de publication:
May 2019
May 2019
Historique:
received:
30
03
2018
accepted:
31
07
2018
pubmed:
15
8
2018
medline:
21
8
2019
entrez:
15
8
2018
Statut:
ppublish
Résumé
Neural insults and neurodegenerative diseases typically result in permanent functional deficits, making the identification of novel pro-regenerative molecules and mechanisms a primary research topic. Nowadays, neuroregenerative research largely focuses on improving axonal regrowth, leaving the regenerative properties of dendrites largely unstudied. Moreover, whereas developmental studies indicate a strict temporal separation of axogenesis and dendritogenesis and thus suggest a potential interdependency of axonal and dendritic outgrowth, a possible axon-dendrite interaction during regeneration remains unexplored. To unravel the inherent dendritic response of vertebrate neurons undergoing successful axonal regeneration, regeneration-competent adult zebrafish of either sex, subjected to optic nerve crush (ONC), were used. A longitudinal study in which retinal ganglion cell (RGC) dendritic remodeling and axonal regrowth were assessed side-by-side after ONC, revealed that-as during development-RGC axogenesis precedes dendritogenesis during central nervous system (CNS) repair. Moreover, dendrites majorly shrank before the start of axonal regrowth and were only triggered to regrow upon RGC target contact initiation, altogether suggestive for a counteractive interplay between axons and dendrites after neuronal injury. Strikingly, both retinal mechanistic target of rapamycin (mTOR) and broad-spectrum matrix metalloproteinase (MMP) inhibition after ONC consecutively inhibited RGC synapto-dendritic deterioration and axonal regrowth, thus invigorating an antagonistic interplay wherein mature dendrites restrain axonal regrowth. Altogether, this work launches dendritic shrinkage as a prerequisite for efficient axonal regrowth of adult vertebrate neurons, and indicates that molecular/mechanistic analysis of dendritic responses after damage might represent a powerful target-discovery platform for neural repair.
Identifiants
pubmed: 30105671
doi: 10.1007/s12035-018-1292-5
pii: 10.1007/s12035-018-1292-5
doi:
Substances chimiques
Matrix Metalloproteinase Inhibitors
0
TOR Serine-Threonine Kinases
EC 2.7.11.1
Types de publication
Journal Article
Langues
eng
Pagination
3175-3192Subventions
Organisme : Onderzoeksraad, KU Leuven (BE)
ID : BOF-OT/14/064
Organisme : Fonds Wetenschappelijk Onderzoek
ID : FWO G0B2315N
Organisme : Fonds Wetenschappelijk Onderzoek
ID : 11P9714N
Organisme : Hercules Foundation
ID : AKUL/09/038
Organisme : Hercules Foundation
ID : AKUL/13/09
Organisme : KU Leuven
ID : PDM/16/093
Organisme : L'Oréal/UNESCO for women in science
ID : 11ZM616N
Organisme : Flemish government agency for innovation by Science and Technology
ID : 2014/14595
Organisme : Flemish goverment agency for innovation by Science and Technology
ID : 2015/141759
Références
J Neurosci. 1999 Mar 15;19(6):2113-21
pubmed: 10066264
Arch Ophthalmol. 1999 Sep;117(9):1216-22
pubmed: 10496394
Nat Neurosci. 2001 Apr;4(4):359-65
pubmed: 11276225
Mol Cell Neurosci. 2001 Jun;17(6):945-56
pubmed: 11414785
J Neurosci. 2002 Feb 1;22(3):920-30
pubmed: 11826121
Science. 2002 Jun 7;296(5574):1860-4
pubmed: 12052959
J Neurocytol. 2001 Jul;30(7):551-92
pubmed: 12118162
Genome Biol. 2002 Jun 18;3(7):RESEARCH0034
pubmed: 12184808
Neuron. 2003 Oct 9;40(2):229-42
pubmed: 14556706
Mol Cell Neurosci. 2005 Jan;28(1):64-78
pubmed: 15607942
Cell. 2004 Dec 17;119(6):873-87
pubmed: 15607982
J Neurobiol. 2005 May;63(2):91-105
pubmed: 15660367
J Cell Sci. 1992 Jan;101 ( Pt 1):69-78
pubmed: 1569130
Proc Natl Acad Sci U S A. 2005 Oct 18;102(42):15230-5
pubmed: 16210248
J Neurosci. 2007 Feb 14;27(7):1712-24
pubmed: 17301179
Mol Neurobiol. 2006 Dec;34(3):205-19
pubmed: 17308353
J Comp Neurol. 2007 Jul 10;503(2):280-96
pubmed: 17492637
Exp Eye Res. 2007 Nov;85(5):678-83
pubmed: 17904550
J Cell Sci Suppl. 1991;15:61-7
pubmed: 1824108
Neurosci Res. 2008 Jul;61(3):281-8
pubmed: 18485507
Dev Neurobiol. 2008 Jul;68(8):1107-22
pubmed: 18506771
Gene Expr Patterns. 2008 Jul;8(6):382-8
pubmed: 18599366
Science. 2008 Nov 7;322(5903):963-6
pubmed: 18988856
J Neurochem. 2009 Oct;111(2):600-13
pubmed: 19694906
Annu Rev Neurosci. 2010;33:349-78
pubmed: 20367247
J Exp Neurosci. 2010 Jul 13;2010(4):17-33
pubmed: 20740047
BMC Biol. 2010 Sep 28;8:126
pubmed: 20920150
Neural Dev. 2010 Nov 02;5:29
pubmed: 21044295
Dev Neurobiol. 2012 Mar;72(3):429-61
pubmed: 21595047
Development. 2011 Nov;138(22):4831-41
pubmed: 22007133
Nat Rev Neurosci. 2012 Feb 15;13(3):183-93
pubmed: 22334213
PLoS One. 2012;7(2):e31061
pubmed: 22347429
Curr Opin Neurobiol. 2012 Oct;22(5):805-11
pubmed: 22575709
Neuron. 2012 Sep 6;75(5):762-77
pubmed: 22958818
Prog Neurobiol. 2013 Jun;105:60-78
pubmed: 23567503
PLoS Biol. 2013;11(6):e1001572
pubmed: 23750116
Trends Genet. 2013 Nov;29(11):611-20
pubmed: 23927865
J Neurosci. 2013 Oct 30;33(44):17444-57
pubmed: 24174678
Neuroscience. 2014 Feb 14;259:13-24
pubmed: 24295634
Restor Neurol Neurosci. 2014;32(3):391-402
pubmed: 24398723
Oncotarget. 2014 Feb 15;5(3):788-801
pubmed: 24553191
Front Neural Circuits. 2014 Feb 11;8:9
pubmed: 24574975
Curr Opin Neurobiol. 2014 Aug;27:165-70
pubmed: 24762653
Curr Opin Neurobiol. 2014 Aug;27:186-91
pubmed: 24769541
PLoS One. 2014 Aug 27;9(8):e106010
pubmed: 25162623
Cell Death Differ. 2015 Apr;22(4):612-25
pubmed: 25257176
Front Neuroanat. 2014 Oct 20;8:116
pubmed: 25368556
Proc Natl Acad Sci U S A. 2015 Feb 24;112(8):2593-8
pubmed: 25675503
Mol Cell Neurosci. 2015 Sep;68:92-102
pubmed: 25913150
Front Cell Neurosci. 2015 Apr 09;9:118
pubmed: 25914619
Neural Regen Res. 2015 Apr;10(4):559-61
pubmed: 26170813
Front Cell Neurosci. 2015 Jul 07;9:251
pubmed: 26217179
Neurobiol Dis. 2016 Jan;85:99-110
pubmed: 26459109
J Comp Neurol. 2016 May 1;524(7):1472-93
pubmed: 26509469
Exp Neurol. 2017 Jan;287(Pt 3):365-373
pubmed: 26746987
Mol Neurobiol. 2017 Apr;54(3):2114-2125
pubmed: 26924318
Development. 2016 Mar 1;143(5):741-53
pubmed: 26932669
Brain Res. 1989 Apr 3;483(2):335-46
pubmed: 2706525
Proc Natl Acad Sci U S A. 2016 May 17;113(20):E2852-60
pubmed: 27078101
Brain Pathol. 2017 Mar;27(2):181-189
pubmed: 27098187
J Cell Biol. 2016 Jul 4;214(1):103-19
pubmed: 27268498
Curr Opin Genet Dev. 2016 Oct;40:41-47
pubmed: 27281280
J Neurosci. 1989 Sep;9(9):3123-45
pubmed: 2795157
eNeuro. 2017 Aug 29;4(4):
pubmed: 28856242
PLoS One. 2017 Sep 19;12(9):e0184672
pubmed: 28926622
Brain Struct Funct. 2018 Mar;223(2):545-567
pubmed: 29189905
J Neurosci. 1988 Nov;8(11):4239-61
pubmed: 3183722
J Comp Neurol. 1986 Dec 15;254(3):382-402
pubmed: 3794013
Proc Natl Acad Sci U S A. 1985 Sep;82(17):6006-9
pubmed: 3898077
Neurosci Res. 1993 Jan;16(1):33-7
pubmed: 8387163
J Neurosci. 1998 Oct 1;18(19):7836-46
pubmed: 9742152